REGENXBIO Inc. (RGNX)
RGNX price $7.17 0.00 0.00%
- Ticker
- RGNX
- Price
- $7.17
- Change
- 0.00 0.00%
- Market cap
- $473.31M
- P/E
- -1.89
- Forward P/E
- 10.78
- Sector
- Healthcare
- Industry
- Biotechnology
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an…